NCT06441916View on ClinicalTrials.gov

Bioequivalence Study of Dabigatran Etexilate Capsules 150 mg in Healthy Thai Volunteers Under Fasting Conditions

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 25, 2024

Primary Completion Date

October 8, 2024

Study Completion Date

November 7, 2024

Conditions
Healthy VolunteerDabigatranBioequivalence Study
Interventions
DRUG

Dabigatran Etexilate Capsules 150 mg

Dabigatran Etexilate

Sponsors
All Listed Sponsors
lead

International Bio service

NETWORK

NCT06441916 - Bioequivalence Study of Dabigatran Etexilate Capsules 150 mg in Healthy Thai Volunteers Under Fasting Conditions | Biotech Hunter | Biotech Hunter